Compare WKHS & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WKHS | SRTS |
|---|---|---|
| Founded | 2007 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.3M | 46.9M |
| IPO Year | 2008 | 2016 |
| Metric | WKHS | SRTS |
|---|---|---|
| Price | $3.59 | $2.84 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $21.00 | $7.00 |
| AVG Volume (30 Days) | ★ 232.7K | 98.5K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $763,173.00 | ★ $27,482,000.00 |
| Revenue This Year | $89.23 | $2.00 |
| Revenue Next Year | $28.84 | $34.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.53 | $2.66 |
| 52 Week High | $11.80 | $5.92 |
| Indicator | WKHS | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 53.61 | 28.58 |
| Support Level | $3.22 | N/A |
| Resistance Level | $4.18 | $3.62 |
| Average True Range (ATR) | 0.39 | 0.21 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 42.41 | 17.31 |
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric vehicles, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.